Clinical Trials Logo

Clinical Trial Summary

The standard treatment for head and neck cancer relapses in previously irradiated patients is controversial. Reirradiation has had some success, but many patients still die from their disease. Cetuximab is helpful in relapsed head and neck cancer, and it improves the effectiveness of radiation in some head and neck cancer patients. But, it has not been studied with reirradiation. The purpose of this study is to see the effects, both good and bad, of reirradiation with cetuximab.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00934518
Study type Interventional
Source Milton S. Hershey Medical Center
Contact
Status Withdrawn
Phase Phase 2
Start date July 2009
Completion date July 2011

See also
  Status Clinical Trial Phase
Recruiting NCT05057013 - HMBD-001 in Advanced HER3 Positive Solid Tumours Phase 1/Phase 2